365 related articles for article (PubMed ID: 34948400)
1. SARS-CoV-2 Exacerbates Beta-Amyloid Neurotoxicity, Inflammation and Oxidative Stress in Alzheimer's Disease Patients.
Chiricosta L; Gugliandolo A; Mazzon E
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948400
[TBL] [Abstract][Full Text] [Related]
2. Protein Expression of Angiotensin-Converting Enzyme 2 (ACE2) is Upregulated in Brains with Alzheimer's Disease.
Ding Q; Shults NV; Gychka SG; Harris BT; Suzuki YJ
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33567524
[TBL] [Abstract][Full Text] [Related]
3. Investigating the Potential Shared Molecular Mechanisms between COVID-19 and Alzheimer's Disease via Transcriptomic Analysis.
Fan Y; Liu X; Guan F; Hang X; He X; Jin J
Viruses; 2024 Jan; 16(1):. PubMed ID: 38257800
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 and Alzheimer's disease: how one crisis worsens the other.
Xia X; Wang Y; Zheng J
Transl Neurodegener; 2021 Apr; 10(1):15. PubMed ID: 33941272
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 and Alzheimer's Disease Share Common Neurological and Ophthalmological Manifestations: A Bidirectional Risk in the Post-Pandemic Future.
Amadoro G; Latina V; Stigliano E; Micera A
Cells; 2023 Nov; 12(22):. PubMed ID: 37998336
[TBL] [Abstract][Full Text] [Related]
6. Neuropathological findings in Down syndrome, Alzheimer's disease and control patients with and without SARS-COV-2: preliminary findings.
Granholm AE; Englund E; Gilmore A; Head E; Yong WH; Perez SE; Guzman SJ; Hamlett ED; Mufson EJ
Acta Neuropathol; 2024 May; 147(1):92. PubMed ID: 38801558
[TBL] [Abstract][Full Text] [Related]
7. Action of the Purinergic and Cholinergic Anti-inflammatory Pathways on Oxidative Stress in Patients with Alzheimer's Disease in the Context of the COVID-19 Pandemic.
Simões JLB; Sobierai LD; Leal IF; Dos Santos MVR; Coiado JV; Bagatini MD
Neuroscience; 2023 Feb; 512():110-132. PubMed ID: 36526078
[TBL] [Abstract][Full Text] [Related]
8. Analysis and Identification Genetic Effect of SARS-CoV-2 Infections to Alzheimer's Disease Patients by Integrated Bioinformatics.
Wang F; Xu J; Xu SJ; Guo JJ; Wang F; Wang QW
J Alzheimers Dis; 2022; 85(2):729-744. PubMed ID: 34776447
[TBL] [Abstract][Full Text] [Related]
9. Potential Novel Role of COVID-19 in Alzheimer's Disease and Preventative Mitigation Strategies.
Naughton SX; Raval U; Pasinetti GM
J Alzheimers Dis; 2020; 76(1):21-25. PubMed ID: 32538855
[TBL] [Abstract][Full Text] [Related]
10. The amplification of CNS damage in Alzheimer's disease due to SARS-CoV2 infection.
Nuovo GJ; Suster D; Sawant D; Mishra A; Michaille JJ; Tili E
Ann Diagn Pathol; 2022 Dec; 61():152057. PubMed ID: 36334414
[TBL] [Abstract][Full Text] [Related]
11. Exposure to urban particulate matter alters responses of olfactory mucosal cells to SARS-CoV-2 infection.
Shahbaz MA; Kuivanen S; Mussalo L; Afonin AM; Kumari K; Behzadpour D; Kalapudas J; Koivisto AM; Penttilä E; Löppönen H; Jalava P; Vapalahti O; Balistreri G; Lampinen R; Kanninen KM
Environ Res; 2024 May; 249():118451. PubMed ID: 38341073
[TBL] [Abstract][Full Text] [Related]
12. Systematic Review of the Common Pathophysiological Mechanisms in COVID-19 and Neurodegeneration: The Role of Bioactive Compounds and Natural Antioxidants.
Choe K; Park HY; Ikram M; Lee HJ; Park TJ; Ullah R; Kim MO
Cells; 2022 Apr; 11(8):. PubMed ID: 35455977
[TBL] [Abstract][Full Text] [Related]
13. Human-derived air-liquid interface cultures decipher Alzheimer's disease-SARS-CoV-2 crosstalk in the olfactory mucosa.
Shahbaz MA; Kuivanen S; Lampinen R; Mussalo L; Hron T; Závodná T; Ojha R; Krejčík Z; Saveleva L; Tahir NA; Kalapudas J; Koivisto AM; Penttilä E; Löppönen H; Singh P; Topinka J; Vapalahti O; Chew S; Balistreri G; Kanninen KM
J Neuroinflammation; 2023 Dec; 20(1):299. PubMed ID: 38098019
[TBL] [Abstract][Full Text] [Related]
14. Aging whole blood transcriptome reveals candidate genes for SARS-CoV-2-related vascular and immune alterations.
de Almeida Chuffa LG; Freire PP; Dos Santos Souza J; de Mello MC; de Oliveira Neto M; Carvalho RF
J Mol Med (Berl); 2022 Feb; 100(2):285-301. PubMed ID: 34741638
[TBL] [Abstract][Full Text] [Related]
15. Spike Protein Fragments Promote Alzheimer's Amyloidogenesis.
Cao S; Song Z; Rong J; Andrikopoulos N; Liang X; Wang Y; Peng G; Ding F; Ke PC
ACS Appl Mater Interfaces; 2023 Aug; 15(34):40317-40329. PubMed ID: 37585091
[TBL] [Abstract][Full Text] [Related]
16. Lactoferrin as Immune-Enhancement Strategy for SARS-CoV-2 Infection in Alzheimer's Disease Patients.
Bartolomé F; Rosa L; Valenti P; Lopera F; Hernández-Gallego J; Cantero JL; Orive G; Carro E
Front Immunol; 2022; 13():878201. PubMed ID: 35547737
[TBL] [Abstract][Full Text] [Related]
17. Network medicine links SARS-CoV-2/COVID-19 infection to brain microvascular injury and neuroinflammation in dementia-like cognitive impairment.
Zhou Y; Xu J; Hou Y; Leverenz JB; Kallianpur A; Mehra R; Liu Y; Yu H; Pieper AA; Jehi L; Cheng F
Alzheimers Res Ther; 2021 Jun; 13(1):110. PubMed ID: 34108016
[TBL] [Abstract][Full Text] [Related]
18. Exploring the Paradox of COVID-19 in Neurological Complications with Emphasis on Parkinson's and Alzheimer's Disease.
Rai SN; Tiwari N; Singh P; Singh AK; Mishra D; Imran M; Singh S; Hooshmandi E; Vamanu E; Singh SK; Singh MP
Oxid Med Cell Longev; 2022; 2022():3012778. PubMed ID: 36092161
[TBL] [Abstract][Full Text] [Related]
19. Ubiquity of the SARS-CoV-2 receptor ACE2 and upregulation in limbic regions of Alzheimer's disease brain.
Zhao Y; Li W; Lukiw W
Folia Neuropathol; 2021; 59(3):232-238. PubMed ID: 34628788
[TBL] [Abstract][Full Text] [Related]
20. Links between COVID-19 and Alzheimer's Disease-What Do We Already Know?
Rudnicka-Drożak E; Drożak P; Mizerski G; Zaborowski T; Ślusarska B; Nowicki G; Drożak M
Int J Environ Res Public Health; 2023 Jan; 20(3):. PubMed ID: 36767513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
